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Abstract
Aims
The Z-disc is a crucial structure of the sarcomere and is implicated in mechanosensation/
transduction. Dysregulation of Z-disc proteins often result in cardiomyopathy. We have pre-
viously shown that the Z-disc protein Cytoskeletal Heart-enriched Actin-associated Protein
(CHAP) is essential for cardiac and skeletal muscle development. Furthermore, the CHAP
gene has been associated with atrial fibrillation in humans. Here, we studied the misregu-
lated expression of CHAP isoforms in heart disease.
Methods and results
Mice that underwent transverse aortic constriction and calcineurin transgenic (Tg) mice,
both models of experimental heart failure, displayed a significant increase in cardiac expres-
sion of fetal isoform CHAPb. To investigate whether increased expression of CHAPb post-
natally is sufficient to induce cardiomyopathy, we generated CHAPb Tg mice under the
control of the cardiac-specific αMHC promoter. CHAPb Tg mice displayed cardiac hypertro-
phy, interstitial fibrosis and enlargement of the left atrium at three months, which was more
pronounced at the age of six months. Hypertrophy and fibrosis were confirmed by evidence
of activation of the hypertrophic gene program (Nppa, Nppb, Myh7) and increased collagen
expression, respectively. Connexin40 and 43 were downregulated in the left atrium, which
was associated with delayed atrioventricular conduction. Tg hearts displayed both systolic
and diastolic dysfunction partly caused by impaired sarcomere function evident from a
reduced force generating capacity of single cardiomyocytes. This co-incided with activation
of the actin signalling pathway leading to the formation of stress fibers.
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Conclusion
This study demonstrated that the fetal isoform CHAPb initiates progression towards cardiac
hypertrophy, which is accompanied by delayed atrioventricular conduction and diastolic dys-
function. Moreover, CHAP may be a novel therapeutic target or candidate gene for screen-
ing in cardiomyopathies and atrial fibrillation.
Introduction
Heart disease is a life-threatening and complex multifactorial disease, with both genetic and
environmental risk factors contributing to the onset and progression of the disease. Cardiac
hypertrophy, indicated by an increase in heart size and weight, is an important determinant of
heart disease. Although pathological cardiac hypertrophy is initially a compensatory mecha-
nism in response to stressful conditions such as cardiomyocyte loss or increased pressure over-
load, eventually it leads to impaired cardiac function and progression to heart failure [1–3]. In
addition to the adaptive hypertrophic response of the heart, cardiac hypertrophy can also be
caused by intrinsic genetic defects, affecting sarcomeric and cytoskeletal proteins directly, such
as in hypertrophic and dilated cardiomyopathy (HCM and DCM). Despite the increase in
genetic associations with familial cardiomyopathies, our understanding of molecular regula-
tion and signal pathways involved in heart disease is still limited.
Nearly all genes produce multiple isoforms of mRNAs by alternative splicing or the use of
alternative transcription start sites. These are important mechanisms for generating a variety
of proteins with distinct functions from a single gene. Recently it has been shown that tran-
scriptome-wide changes in mRNA isoforms of sarcomeric genes occur in several forms of
human heart disease, including aortic stenosis [4, 5]. However, it is unknown to what extent
the misregulated isoform expression of a single gene can contribute to heart disease.
Previously, we described a novel protein, named Cytoskeletal Heart-enriched Actin-associ-
ated Protein (CHAP) [6, 7], which is expressed in striated muscle at the Z-disc of sarcomeres.
We identified two isoforms of CHAP (encoded by a single gene), which were differentially
expressed during embryonic and postnatal development. CHAPb is expressed during early
cardiac and skeletal muscle development and is downregulated in adult tissues, whereas
CHAPa is predominantly expressed in adult heart and skeletal muscle. Furthermore, CHAPa,
the longest isoform (978 amino acids (aa)) contains an N-terminal PDZ domain, as well as a
nuclear localization signal (NLS) while CHAPb isoform (749 aa) lacks the PDZ domain. Zebra-
fish and chick orthologues of CHAP, which only express the CHAPa isoform, are present in
the heart during embryonic development from the cardiac crescent stage onwards, and in later
stages are detected in somites and smooth muscle cells [8]. Knock-down of Chap in the zebra-
fish resulted in impaired heart looping, cardiac oedema, decreased cardiac contractility,
impaired skeletal muscle formation and lethality at 6 days post fertilization [6].
Interestingly, Brugada et al were the first to identify the CHAP/SYNPO2L locus as a sus-
ceptibility locus for atrial fibrillation (AF) in a family with autosomal dominant AF [9]. An
independent genome-wide association study (GWAS) in individuals of European ancestry
identified a SNP (rs10824026) upstream of CHAP gene as a novel AF locus[10]. More recently,
whole-exome sequencing in AF patients revealed that a common variant in CHAP (rs3812629,
p.Pro707Leu) was significantly associated with AF [11]. These studies therefore propose the
CHAP gene as a candidate gene for causing human AF. Although it has been established in
animal models that CHAP is essential for cardiac development and function, the role of CHAP
in disease remains unknown.
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Here, we demonstrate that the fetal CHAP isoform (CHAPb) is upregulated in a mouse
model of pressure overload-induced hypertrophy. Transgenic expression of fetal isoform
CHAPb in the postnatal heart displayed characteristic features of heart disease, such as induc-
tion of cardiac hypertrophy, cardiac fibrosis and left atrial enlargement as well as delayed
atrio-ventricular conduction, and overall contractile dysfunction. Furthermore, downstream
activation of actin signaling in these transgenic mice led to the formation of stress fibers.
Together the results indicate that an upregulation of the fetal isoform CHAPb is sufficient to
induce cardiomyopathy.
Methods
Generation of CHAP Tg mice
Full-length cDNA of mouse CHAPb, preceded by a N-terminal FLAG and Kozak consensus
sequence, was fused to the heart-specific murine α-myosin heavy chain (α-MHC) promoter.
At the 3’ end of CHAP a poly-A-signal of the human growth hormone (hGH) was included.
Plasmid DNA was linearized by digestion with NotI, gel purified and dialyzed against Tris-
EDTA (TE) buffer. DNA was injected into pronuclei from mice with a C57BL/6-CBA back-
ground. Transgenic (Tg) founder mice were crossed back (5 generations) to C57BL/6 mice to
obtain a pure background. For genotyping genomic DNA was isolated from mice tail biopsies
and analysed by PCR with a forward primer recognizing the C-terminus of CHAP (5’-TGGT
GAAACCCCGTCTCTAC-3’) and a reverse primer recognizing the hGH polyA signal (5’-C
AGATTTTCCACTCCTGCAC-3’). All animal experiments were carried out in accordance
with Dutch law and approved by the animal experimental committee of the Leiden University
Medical Centre (permit number 09129).
Furthermore, the animal experiments were performed conform the guidelines from Direc-
tive 2010/63/EU of the European Parliament on the protection of animals used for scientific
purposes.
Western blot
CHAP Tg mice and wild type littermates were sacrificed by cervical dislocation. Hearts were
harvested, rinsed in PBS, snap frozen in liquid nitrogen and stored at -80˚C until further use.
Hearts were homogenized using an ultra-turrax tissue separator (IKA, Germany) in T-PER tis-
sue protein extraction reagent (Pierce) supplemented with: protease inhibitor cocktail tablets
(10 μg/ml; Roche, Germany), 0.1 mmol/L dithiothreitol (DTT; Invitrogen) and 1 mmol/L phe-
nylmethanesulfonylfluoride (PMSF; Sigma Aldrich), 5 mmol/L NaF and 1 mmol/L Na3VO4).
Samples were incubated on ice for 15 minutes and centrifuged at 10.000 xg at 4˚C for 10 min-
utes and supernatants were transferred to new tubes. Protein concentration was determined
by the Bradford assay (BioRad) using bovine serum albumin as a standard. Proteins (50μg/
lane) were separated by SDS-page gel electrophoresis and subsequently blotted using Hybond-
P membranes (GE Healthcare) 3 hours at RT. Incubation with the following antibodies was
performed overnight at 4˚C in 5% milk/TBS-Tween (unless stated else): CHAP (1:200, custom
made by Eurogentec MW CHAPa = 140 kDa, MW CHAPb = 110 kDa), actin (1:1000; Milli-
pore BV, MW = 43 kDa), RhoA (1:200, 26C4, Santa Cruz, MW = 24 kDa), alpha-actinin2
(1:800, EA-53, Sigma-Aldrich Chemie, MW = 100 kDa), Ezrin/Moesin/Radixin (1:1000 in 5%
BSA/TBS-Tween, Cell Signaling Technology MW moesin = 75 kDa, MW Ezrin and Radixin =
80 kDa), Cofilin (1:1000 in 5% BSA/TBS-Tween, Cell Signaling Technology, MW = 19 kDa),
SRF (1:200, G20, Santa Cruz, MW = 40–67 kDa), Myocyte Enhancer Factor 2 (MEF2, 1:200,
C21, Santa Cruz, MW = 40–65 kDa) and GAPDH (1:10000, 6C5, Millipore, MW = 38 kDa).
Peroxidase-conjugated antibodies used were anti-mouse IgG HRP linked antibody (1:1000,
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Cell Signaling Technology) and anti-rabbit HRP linked antibody (1:2000, Cell Signaling Tech-
nology). For the detection of protein bands SuperSignal West Pico Chemiluminescent Sub-
strate (Pierce) was (the substrate) used.
Southern blot analysis
Genomic DNA of wild-type and CHAPb Tg mouse tails was extracted in 0.5 ml tail lysisbuffer
(50 mM Tris pH 8.0, 100 mM EDTA pH 8.0, 100mM NaCl, 1% SDS and 10 mg/ml prot K) at
55 oC overnight. DNA was precipitated by phenol-chloroform extraction and 10 μg DNA was
digested by BamHI (Promega) or XmnI (New England Biolabs) overnight and run on a 1%
agarose gel. Probes were generated using the following primers: 5’- AGGGGTCCAGCTC
TTTGAAC-3’ and 5’-AGGCTTAAAGCGTCCTCCTC-3’. The PCR products were then
radioactively labelled using α-[p32]dATP (PerkinElmer) by random priming (RadPrime, Invi-
trogen). DNA blots (Hybond-N+, GE Healthcare) were hybridized with the radioactive probe
in ExpressHyb Hybridization buffer (Clontech) and visualized by using a Phosphorimager.
RNA isolation and quantitative PCR
Hearts were homogenized in TRIzol (Invitrogen) using an ultra-turrax tissue separator (IKA,
Germany) and RNA was isolated according to the supplier’s protocol. RNA was treated with
DNase (DNA-free, Ambion) and cDNA was made with the iScript kit (BioRad). qPCR was
performed using the CFX96 Real-Time PCR detection system (Bio-Rad). For details on the
primers used see S1 Table. Data were analyzed with Bio-Rad CFX Manager.
Transmission Electron Microscopy (TEM)
Hearts of CHAPb Tg mice and wild type littermates were collected and left ventricles were
used for TEM. For electron microscopy samples were fixed in glutaraldehyde (2.5%) in 0.1
mol/L phosphate buffer for 24 hours, post fixed in 1% OsO4 in 0.1 mol/L cacodylate buffer for
1 hour at 4˚C, dehydrated in a graded ethanol series and embedded in an epoxy resin. Ultra-
thin sections were post stained with uranyl acetate and lead citrate and viewed and imaged
with a FEI Tecnai 12 transmission electron microscope operated at 120 kV and equipped with
an Eagle 4kx4k camera (FEI, Eindhoven, The Netherlands)
Immunohistochemistry
For histological and immunohistochemical analysis hearts were obtained at different time
points (1, 3 and 6 months of age). Mice were sedated by injection of a mixture of 100 μl keta-
mine, 50 μl rompun and 10 μl atropine in 1ml 0.9% NaCl.
For paraffin sections mice were perfused with 0.9% NaCl and subsequently with 4% para-
formaldehyde (PFA). Hearts and other organs (lungs, kidney and liver) were dissected, fixed
over night in 4% PFA, dehydrated by ethanol-xylene series and embedded in paraffin. Serial
heart sections (5 μm) were made, mounted on starfrost slides (Knittel) and followed by heama-
toxilin-eosin (HE) staining, Sirius red staining, and immunohistochemistry as indicated. For
all antibody stainings, except Myosin Light Chain 2a (MLC2a), microwave antigen retrieval
in citrate buffer (pH 6) was applied. Endogenous peroxidase was blocked by incubating the
slides in 0.3% H2O2 in PBS. Sections were incubated overnight at room temperature with Con-
nexin40 antibody (1:100; Santa Cruz), Connexin43 (1:500; Zymed), MLC2a (1:4000 gift from
S. Kubalak) and Troponin I (TnI, 1:800; Santa Cruz). Secondary antibody used was biotin-
labeled goat anti-rabbit (Vector Labs) or biotin-labeled horse anti-goat (Vector Labs). Subse-
quently, the sections were incubated with Vectastain ABC staining kit (Vector Labs) for 45
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min. Slides were rinsed in PBS and Tris/Maleate (pH 7.6). 3–3’-diaminobenzidine tetrahy-
drochloride (DAB, Sigma-Aldrich Chemie) was used as chromogen and Mayer’s heamatoxylin
as counterstaining. Finally, slides were dehydrated and mounted with Entellan (Merck).
For cryosections mice were perfused with 0.9% NaCl only, then hearts were isolated. Pro-
cessing of hearts for cryosections was adapted from Bajanca et al. [12] Serial sections (5 μm)
were made and mounted on starfrost slides (Knittel) and antibody staining was performed as
previously described.[13] Antibodies used were CHAP (1:50), myomesin (1:50 E. Elher), α-
actinin (Sigma Aldrich), RhoA (1:100, 26C4, Santa Cruz) and pERM (1:50, Cell Signaling
Technology). Secondary antibodies used are Cy-3 conjugated anti-mouse (1:250, Jackson
Immunoresearch Laboratories) and Alexa488 conjugated anti-rabbit (1:200, Invitrogen). Cell
nuclei were counterstained with DAPI (Molecular Probes). Stainings were analyzed with SP5
confocal microscope (Leica).
Volume measurements
The volume of the atria and ventricle was estimated by the Cavalieri principle of volume esti-
mation. Serial sections were stained for an atrial marker, MLC2a, or cTnI to identify the ven-
tricle. Then a grid was used to estimate the surface of the stained section and the distance
between the sections was used to estimate the volume as previously described[14].
Magnetic Resonance Imaging (MRI)
For MRI measurements 4 wild type and 5 CHAPb transgenic mice of 6 months of age were used.
Animals were sedated by 4% isoflurane and MRI images were produced as described below.
All experiments were performed on a vertical 9.4T magnet (Bruker, Ettlingen, Germany)
supplied with an actively shielded Micro2.5 gradient system of 1T/m and a 30 mm transmit/
receive birdcage RF coil, using Para vision 4.0 software.
MRI protocols
In vivo:
At the start of each examination, several 2D FLASH scout images were recorded in the
transverse and axial plane of the heart to determine the orientation of the heart.
A modified FLASH sequence with a navigator echo (IntraAngio) was used for retrospective
CINE MRI with the following parameters:
Short-axis (oriented roughly perpendicular to the septum) and long-axis (oriented through
the apex and aortic valve) cardiac cine MRI images with the navigator positioned through the
aortic arch were acquired with the following parameters: hermite-shaped RF pulse 1 ms; FA
10˚; 200 avarages, TR 68.1 ms; TE 1.86 ms; reconstruction of 18 cardiac frames; FOV 2.562.56
cm2; matrix 192192; in-plane resolution 133 μm, slice thickness 1.0 mm; total acquisition
time approximately 30 min.
Heart function was assessed using MASS for Mice 5.1 software package (Leiden, The Neth-
erlands) by manual delineation of LV and RV borders.
Based on these segmented areas, LV and RV area, end-diastolic volume (EDV), end-systolic
volume (ESV), LV stroke volume (SV), and LV ejection fraction were computed automatically.
Electrocardiogram (ECG) measurements
ECG measurements on wild type and CHAPb Tg mice of 6 months of age were performed as
described in Henkens et al. [15]. In brief, before ECG recording, animals were anesthetized by
inhalation of 4% isoflurane. Anesthesia was maintained at 2% isoflurane administration and
ECG measurements were recorded for at least one minute. The data were analysed with the
program LEADS and heart rate, PR duration and P duration were calculated.
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Sarcomere measurements
Hearts of CHAPb Tg mice and wild type litter mates were isolated at different time points (1
month and 3 months) and snap frozen in liquid nitrogen. Single cardiomyocytes were ob-
tained by grinding hearts in liquid nitrogen. Cardiomyocytes were defrosted in relaxing solu-
tion (pH 7.0; 1 mmol/L free Mg2+ 1, 145 mmol/L KCl, 2 mmol/L EGTA, 4 mmol/L ATP, 10
mmol/L imidazole). Then cardiomyocytes were treated with relaxing solution containing 1%
Triton-x-100 for 5 minutes, to remove the membranes. Cardiomyocytes were washed twice in
relaxing solution to remove Triton-X-100. Single cardiomyocytes were placed between a force
transducer and piezoelectric motor. Isometric force measurements were performed at 15˚C
and a sarcomere length, measured in relaxing solution, of 2.2 μm. The calcium concentrations
of relaxing and activation solution (pH 7.1) were 10−3 and 30 μmol/L, respectively. Solutions
with intermediate free [Ca2+] were obtained mixing relaxing and activation solution. The first
control activation was performed at maximum [Ca2+] and thereafter, the resting sarcomere
length was set to 2.2 μm again. The second control measurement was performed to calculate
the maximum isometric tension (force divided by cross-sectional area). The next measure-
ments (4–5) were performed in submaximal [Ca2+], followed by a control measurement. Force
values obtained from submaximal [Ca2+] were normalized to control values.
Protein phosphorylation
Protein phosphorylation of sarcomeric proteins was measured in hearts of CHAPb Tg and
wild type litter mates at 3 months of age. Briefly, samples were separated by SDS-PAGE and
gels were stained by SYPRO Ruby stain or Pro-Q Diamond Phosphoprotein Stain. A detailed
description of the procedure can be found in Zaremba et al. [16].
Statistical analysis
Data were analysed with GraphPad Prism. All data are expressed as mean + the standard error
of the mean (SEM). Statistical analysis between two groups was performed using Student’s
unpaired t-test, or t-test with Welch’s correction where appropriate (Fig 1C and 1D). All analy-
ses were 2-tailed and a P value less than 0.05 was considered statistically significant.
Results
CHAPb is upregulated in cardiac hypertrophy
Many genes expressed during heart development are reactivated during heart failure. Since we
previously identified an important role for CHAP during cardiac development we investigated
both isoforms of CHAP (S1 Fig) in an in vivo model of experimental heart failure.
Transgenic mice with cardiac-specific overexpression of a constitutively active form of cal-
cineurin display a massive cardiac hypertrophic response [3]. In hearts of adult calcineurin Tg
mice, expression of both isoforms was increased compared to expression in wild type (wt)
mice at RNA (Fig 1A) and protein level (Fig 1B). Next we investigated the expression of cardiac
Chap in a model of pressure overload-induced hypertrophy, transverse aortic constriction
(TAC). Expression of ChapA was not significantly changed at different times after TAC (Fig
1C), whereas ChapB was significantly increased as soon as 1 day of TAC and was maintained
until three weeks of TAC, as compared to sham controls (Fig 1D). In summary, experimental
models of cardiac hypertrophy demonstrated increased levels of both CHAP isoforms,
although reactivation of fetal isoform CHAPb was predominant in the pressure overload
model.
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Ectopic CHAP expression in transgenic mice
In order to investigate a possible role for CHAPb in the development of cardiac hypertrophy,
we generated cardiac-specific CHAPb Tg mice. These Tg mice express a N-terminal FLAG-
tagged CHAPb isoform in the postnatal heart under control of the cardiac-specific α-myosin
heavy chain (MHC) promoter (S2A Fig). Injection into C57BL/6-CBA zygotes resulted in
three CHAPbTg founders among 30 animals, that showed different copy number levels as
determined by Southern blot (S2B Fig). Analysis of hearts of the Tg line with intermediate
copy numbers by qPCR demonstrated upregulation of ChapB compared to wt mice (S2C Fig).
Western blot analysis of Tg hearts showed a strong increase in CHAPb protein levels (110
kDa), when compared to wt hearts. This was confirmed by the presence of anti-FLAG immu-
noreactivity in the Tg hearts only (S2D Fig).
CHAPb expression in adult mouse heart leads to enlarged atria
Southern blot analysis of founders showed high CHAPb copy number in transgenic line 29
and intermediate CHAPb copy number in line 14 compared to endogenous genomic levels of
Fig 1. Chap is upregulated in mouse models of pathological cardiac hypertrophy. (A) Quantitative RT-PCR showing
increased mRNA levels of both ChapA and B in hearts of transgenic mice expressing constitutively active calcineurin A
(CnA Tg) (WT: n = 5, CnA Tg: n = 6; Students t-test: CnA Tg vs WT). (B) Western blot for CHAPa and CHAPb in adult
wildtype hearts CnA Tg hearts (WT: n = 5, CnA Tg: n = 6). In wildtype hearts, CHAPa is the dominant isoform while in CnA
Tg hearts both CHAPa and b were significantly upregulated. (C) Quantitative RT-PCR for ChapA showing mice subjected
to transverse aortic constriction (TAC) for 1 day, 1 week and 3 weeks (n = 4, n = 4, and n = 10 respectively), with no
significant regulation of ChapA mRNA compared to sham controls (n = 3, n = 3 and n = 7 respectively). (D) Quantitative
RT-PCR for ChapB showing mice subjected to TAC with significant upregulation of ChapB mRNA (number of mice are
same as in C). Gapdh was used as internal control in all experiments. T-test with Welch’s correction TAC vs sham: *,
p<0.05; **, p<0.01;***, p<0.001.
https://doi.org/10.1371/journal.pone.0189139.g001
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CHAP (S2B Fig). The highest CHAPb expressing founder (Tg line 29) died after 7 months,
without progeny. Progeny of the Tg line 14 died spontaneously at approximately 6 months.
Hearts of both transgenic lines displayed comparable phenotypes with enlargement of left and
right atrium (S3A and S3B Fig). Interestingly, all mice that spontaneously died displayed
severely enlarged left atria for both transgenic lines. Histological analysis revealed that the left
atrium was filled with a chronic and organized thrombus. Furthermore, thickness of the sep-
tum, left and right ventricle wall was increased, suggesting cardiac hypertrophy. This was con-
firmed by hypertrophy of cardiomyocytes at higher magnifications (S3C Fig).
Expression of fetal isoform CHAPb in adult hearts leads to cardiac
hypertrophy
We analyzed CHAPbTg mice at one, three and six months of age. At one month, hearts of wt
and Tg mice were indistinguishable (S4A–S4C Fig). At three months the left atrium of Tg
hearts was enlarged without signs of thrombus formation (Fig 2A). Tg hearts showed obvious
cardiomyocyte hypertrophy with enlarged nuclei (Fig 2B) and interstitial fibrosis, indicated by
Sirius Red staining (Fig 2C). To determine the extent of cardiac hypertrophy, we measured
atrial and ventricular volume at these ages. Myosin Light Chain 2a (MLC2a) and Troponin I
(TnI) staining were used to identify the atria and ventricle, respectively. As expected, the vol-
umes of the atria at one month was similar in wt and Tg mice (S4D Fig) but at three months,
the left atrial volume of Tg mice was significantly greater than in wt (wt: 2.046 mm3 ± 0.1346
n = 4, Tg: 4.598 mm3 ± 0.3853 n = 4, p< 0.01; Fig 2D) whereas the volumes of the right atria
were similar (wt 2.041 mm3 ± 0.2431 n = 4, Tg 2.114 mm3 ± 0.03001 n = 4, p = NS). Further-
more, despite the hypertrophy evident in individual cardiomyocytes of the left ventricle, the
overall ventricular wall volume was not different in Tg mice (wt 57.81 mm3 ± 6.352 n = 4,
CHAPbTg 51.31 mm3 ± 2.705 n = 4, p = NS).
By six months, left atrial enlargement was consistently more pronounced in Tg mice and
was associated with cardiomyocyte hypertrophy and interstitial fibrosis (Fig 2B and 2C, S5
Fig). Occasionally, intraventricular thrombi were identified (Fig 2E). In general, changes in Tg
hearts were more pronounced at six months, displaying features that resemble cardiomyopa-
thy, including sudden death.
Activation of hypertrophic gene program and fibrosis in CHAPb Tg
hearts
We isolated RNA from left ventricles of six-month-old wt (n = 3) and Tg (n = 3) mice to inves-
tigate gene expression. A hallmark of hypertrophy is re-expression of fetal cardiac genes, such
as atrial natriuretic factor (ANF, Nppa), brain natriuretic peptide (BNP, Nppb) and β-MHC
(Myh7). qPCR analysis showed significant upregulation of Nppa (17.2x, p<0.01, Fig 3A), Nppb
(3.6x, p<0.01, Fig 3B) and Myh7 (28.3x, p = 0.0634, Fig 3C) in Tg hearts. These findings cor-
roborate the hypertrophic response observed morphologically.
Fibrosis is characterized by increased collagen production. To confirm Sirius red evidence,
we analyzed the expression of Collagen I and III, the major fibrin forming collagen types.
Increased expression of Collagen I (3.2x, p = 0.0506, Fig 3D) and III (3.7x, p = 0.0404, Fig 3E)
was indeed observed in Tg animals, as expected. Moreover, mRNA expression of Serca2,
which encodes a protein involved in Ca2+ cycling [17] and is generally down-regulated in car-
diac hypertrophy, was decreased in Tg hearts (Fig 3F).
Finally, we examined endogenous Chap isoforms in Tg mice. ChapA mRNA expression
was similar in wt and CHAPb Tg hearts (Fig 3G) and although endogenous ChapB appeared
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slightly increased, this was not statistically significant (Fig 3I). Exogenous ChapB (Fig 3H) was,
as expected, strongly upregulated in Tg hearts compared to wt.
Fig 2. Hypertrophy and left atrial enlargement in CHAP Tg hearts. (A-C) Wt (left panels) and CHAPb Tg (right panels)
at 3 and 6 months of age. (A) HE stained overview section. The left atrium in CHAPb Tg hearts is enlarged (indicated by *)
compared to wt litter mates. (B) Higher magnification of left ventricle. In the left ventricle of CHAPb Tg hearts the
cardiomyocytes are hypertrophic. (C) Sirius red staining of the left ventricle showing increase in interstitial fibrosis in
CHAPb Tg. (D) Myocardial volume of the left atrium (left panels) and right atrium (right panels) in wt (white bars) and
CHAPb Tg (black bars) hearts at 3 months of age (wt n = 4, Tg n = 4, T-test p< 0.001). (E) CHAPb Tg heart with severe
phenotype showing pronounced atrial enlargement, filled by a thrombus and thickening of the ventricles. Scale bars 1 mm
in A and D, 50 μm in B, C.
https://doi.org/10.1371/journal.pone.0189139.g002
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Expression of ChapB in adult heart leads to loss of Connexins in the left
atrium and conduction disturbances
Since cardiomyopathies are associated with disturbed electrical conductance and cardiac
arrhythmia, we investigated the most predominant Connexin (Cx) isoforms in atria and ven-
tricles. Cx40 is the main isoform expressed in atria. Cx43 is expressed at higher levels in ventri-
cles and at lower levels in the atria [18]. At one month, there was no difference in Cx40 and
Cx43 expression between wt and Tg (S6A and S6B Fig). At three months, however, enlarge-
ment of the left atrium was accompanied by loss of expression of both Cx40 and Cx43,
although expression in the right atrium (S6C and S6D Fig) and ventricles were unchanged.
This decrease in Cx40 levels in the left atrium was more pronounced at six months (Fig 4A).
These findings were confirmed by qPCR, which showed that Cx40 (-23x, p<0.01, Fig 4B)
and 43 (-6.9x, p<0.01, S5E Fig) were both downregulated in the left atrium. Similar to the pro-
tein data, mRNA expression of Cx40 and Cx43 in the right atrium was unchanged (Fig 4C and
S6F Fig).
To investigate whether the loss of expression of Cx40 and 43 was correlated with conduc-
tion disturbances, we performed ECG measurements of wt and Tg mice. Heart rate was similar
between wild type and Tg mice (S6G Fig) whereas the PR interval was increased in Tg mice
(wt 40,89 ms ± 1,150 n = 3, Tg 49,83 ± 1,784 n = 8, p<0.05; Fig 4E) indicating a conduction
Fig 3. Expression of hypertrophy markers and collagens in left ventricle. qPCR analysis showing mRNA
expression of Nppa (A), Nppb (B), Myh7 (C), CollagenI (D) CollagenIII (E), Serca2 (F), ChapA (G), ChapB (H) and
endogenous ChapB (I) in the left ventricle of wt (white bars) and CHAPb Tg (black bars) mice. Gapdh, Pgk and H2a
were used as internal controls. (wt n = 3, Tg n = 3, T-test: *, p<0.05; **,p<0.01;***, p<0.001).
https://doi.org/10.1371/journal.pone.0189139.g003
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delay from atria to ventricles. No signs of atrial fibrillation were observed, as the duration of
the P-top was unchanged (wt 7,367 ms ± 0,9260 n = 3, Tg 6,955 ms ± 0,4934 n = 8, p = ns; Fig
4D) [19].
CHAPb Tg mice show decreased cardiac performance
To determine whether the phenotypic changes in Tg hearts affected cardiac performance, we
performed MRI measurements on 4 wt and 5 Tg male mice at six months. Enlargement of the
left atrium was clearly visible in the scans. We then calculated the functional parameters of the
Fig 4. Decreased Connexin 40 expression in CHAPb Tg left atrium at 6 months of age leads to atrio-ventricular
conduction delay. (A) Immunohistochemical staining showing Connexin 40 expression in wt (left panels) and CHAPb Tg
(right panels) left (upper panels) and right (lower panels) atria. (B,C) qPCR analysis of Connexin 40 expression in the left
(B) and right (C) atrium (wt n = 3, Tg n = 3 T-test, **,p<0.01). (D,E) ECG analysis of wt (n = 3) and CHAPb Tg (n = 8) mice
showing P duration (N.S.) (D) and PR interval (p = 0.02, T-test) (E). Scale bars 50 μm.
https://doi.org/10.1371/journal.pone.0189139.g004
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left and right ventricle. The results of the left ventricle are shown in Fig 5. Representative scans
for wt and Tg are shown in Fig 5A. Both end diastolic volume (wt 45.81 μl ± 2.297 n = 4, Tg
29.08 μl ± 1.176 n = 5, p<0.01; Fig 5B) and end systolic volume (wt 15.72 μl ± 2.570 n = 4, Tg
7.474 μl ± 1.702 n = 5, p<0.05; Fig 5C) were significantly decreased, resulting in a similar ejec-
tion fraction in wt and Tg mice (wt 66.26% ± 3.972 n = 4, Tg 74.35% ± 5.376 n = 5, p = ns; Fig
5D). However, the cardiac output was significantly decreased in Tg mice compared to wt (wt
1559 μl/min ± 32.20 n = 4, Tg 1083 μl/min ± 117.6 n = 5, p<0.01; Fig 5E). Both the left ventric-
ular mass of end diastole (wt 77.79 mg ± 2.572 n = 4, Tg 58.11 mg ± 5.399 n = 5, p<0.05; Fig
5F) and end systole (wt 93.97 ± 1.784 n = 4, Tg 71.39 ± 5.127 n = 5, p<0.01; Fig 5G) was
decreased in Tg mice. Similar data were obtained for the right ventricle (S7 Fig). Overall, these
data show that CHAPb overexpression impairs diastolic and systolic function in both the left
and right ventricle.
CHAPb Tg mice display decreased force generating capacity of cardiac
sarcomeres
To investigate the functional properties of cardiac sarcomeres, we measured force develop-
ment at different calcium concentration in membrane-permeabilized single cardiomyocytes
(Fig 5H) from wt and Tg sarcomeres at one month. We observed no difference in passive force
(Fig 5I) whereas at the highest calcium concentration (30 μmol/L) force development was
Fig 5. CHAPb Tg mice show decrease cardiac performance. (A) Representative 4-chamber view MRI images of wt and CHAPb Tg heart.
Enlarged LA in CHAPb Tg is indicated with *. (B-G) MRI measurements of the left ventricle of wt (n = 4, white bars) and CHAPb Tg (n = 5, black
bars) animals at 6 months of age. ED volume (B), ES volume (C), ejection fraction (D), cardiac output (E), LV mass ED (F) and LV mass ES (G). (H)
Experimental setup for single membrane-permeabilized cardiomyocyte measurements to determine sarcomere function. Sarcomere force
measurements at one month of age showed no difference in passive force (I; Fpas), while maximum force (J; Fmax) and Ca2+-sensitivity (K; pCa50)
were reduced in CHAPb Tg (n = 11, black bars) compared to wt (n = 12, white bars). ED (end diastolic), ES (end systolic) and LV (left ventricular). t-
test: *, p<0.05; **, p<0.01; ***, p<0.001.
https://doi.org/10.1371/journal.pone.0189139.g005
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decreased in Tg cardiomyocytes (wt 50.40 kN/m2 ± 4.911 n = 12, Tg 30.23 kN/m2 ± 4.346
n = 11, p = 0,006; Fig 5J). Furthermore, sarcomere Ca2+-sensitivity (pCa50, the calcium con-
centration at which half of the maximum force was generated) was also decreased in Tg sarco-
meres compared to wt (wt 5.53 ± 0.02 n = 12, CHAPb Tg 5.45 ± 0.02 n = 11, p = 0,0046; Fig
5K). The reduction in both maximal force and pCa50 shows that Tg sarcomeres have less force
generating capacity compared to wt sarcomeres. The phosphorylation status of the sarcomeric
proteins troponin I and T, myosin binding protein C and myosin light chain 2, remained
unchanged (S8 Fig). These results correlated with those from MRI, where we found decreased
diastolic function, indicating a stiffer heart.
Sarcomeric organization is disturbed in CHAPb Tg hearts
Next we investigated the sarcomeric organization in cryosections of wt and Tg hearts. Immu-
nohistochemical staining showed that CHAP and α-actinin-2 were co-localized at the Z-disc
of wt and Tg cardiomyocytes (Fig 6A), whereas CHAP did not overlap with myomesin (M-
band protein; S9 Fig). However, in the Tg hearts, CHAP was also localized in fibers, which
appeared to be perpendicular to the sarcomeres and resembled the formation of stress fibers.
These fibers stained with α-actinin (Fig 6A), but not myomesin (S9 Fig). These stress fibers
were already visible at one month. To study the sarcomeres in more detail we performed
Transmission Electron Microscopy on 6 months old wt and Tg hearts. Organization of wt sar-
comeres was regular with well-formed Z-discs, M-bands and intercalated discs, whereas Tg
sarcomeres were irregular and both Z-disc and intercalated discs were disorganized (Fig 6B).
Interestingly, the M-Band was not clearly visible in sarcomeres of CHAPb Tg mice.
Activation of the actin signalling pathway in CHAPb Tg hearts
Since synaptopodin, a family member of CHAP, has been associated with actin signalling in
brain and kidney and since this pathway is involved in cardiac hypertrophy, we investigated
the actin signalling pathway in Tg hearts. Staining of GTPase RhoA, a key component of the
actin signalling pathway, in hearts of six months showed sarcomeric expression pattern in wt,
while in Tg expression was increased and, interestingly, was displaced from its sarcomeric
localization (Fig 6C). To further confirm the CHAPb-dependent activation of actin signalling,
we examined downstream effectors. Indeed, phosphorylation of Ezrin/radixin/moesin (ERM),
a family of proteins involved in Rho-dependent signalling and linking the actin cytoskeleton
to the plasma membrane [20, 21], was increased in Tg hearts and displayed a similar localiza-
tion as CHAP (S10 Fig). Increased protein expression levels of RhoA, actin, α-actinin, ERM,
cofilin, and downstream actin-dependent transcription factors serum response factor (SRF)
and myocyte enhancer factor-2 (MEF2) in hearts of Tg compared to wt (Fig 6D) confirmed
these findings. These results suggested CHAPb dependent activation of the actin-signalling
pathway, from membrane to the nucleus, which may contribute to the molecular, phenotypic
and functional alterations observed in the Tg mice.
Discussion
Here we show that the Z-disc protein CHAP is upregulated in experimental models of cardiac
hypertrophy and that cardiac-specific overexpression of the fetal isoform CHAPb is sufficient
to induce various aspects of heart remodelling and decreased heart function. CHAP was ini-
tially identified as a gene up-regulated during the differentiation of human embryonic stem
cell-derived to cardiomyocytes [7]. In mice and human two CHAP isoforms were identified
which differ in their temporal expression patterns: the shorter isoform CHAPb is expressed
during embryonic development in the heart, somites and muscle precursors, whilst CHAPa is
Z-disc protein CHAPb induces cardiomyopathy in the postnatal heart
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Fig 6. Sarcomeric organization is disturbed and actin signalling is increased in CHAPb Tg hearts. (A)
Immunostaining for CHAP (green) and α-actinin (red) show stress fiber formation (white arrows) in CHAP Tg
hearts (B) Electron microscopy analysis of wt and CHAPb Tg hearts at 6 months of age. In CHAPb Tg the
sarcomeres were irregular and Z-discs and intercalated discs (black arrow heads) are disorganized, while M-
bands are absent (white arrow heads) (C) Wt and CHAPb Tg hearts at 6 months of age stained for RhoA
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expressed in the adult heart and skeletal muscle. Morpholino knockdown of Chap in zebrafish
showed that it is essential for heart development. Furthermore, overexpression of “embryonic”
CHAPb, but not “adult” CHAPa, in rat cardiomyocytes led to dissociation of α-actinin-2 from
the Z-disc [6, 22, 23]. Here we show that CHAPb Tg mice displayed features which are compa-
rable to cardiomyopathy, such as cardiac hypertrophy, interstitial fibrosis, diastolic dysfunc-
tion, and disturbed electrical conductance, which led to higher mortality.
CHAPb induces cardiac hypertrophy, left atrial enlargement and fibrosis
CHAPb overexpression in Tg hearts was apparent both in qPCR and Western blot analysis.
This had no effect at one month but by three months, molecular markers of hypertrophy were
upregulated and cardiomyocyte hypertrophy without ventricular wall thickening, left atrial
enlargement and interstitial fibrosis were clearly evident. This was more pronounced at six
months and occasionally accompanied by wall thickening of the left and right ventricles and
septum. In agreement with increasing severity of the phenotype, Tg mice died spontaneously
from six months of age. Occasionally thrombi were found in the left atria, which may have
disturbed blood flow in the left atrium and impaired ventricular filling. Reduced ventricular
filling may eventually contribute to pulmonary venous congestion and development of pulmo-
nary oedema. Although we did not observe pulmonary oedema overall (indicated by preserved
lung weights) in Tg mice, we cannot exclude that this occurred in individual mice. Indeed,
occasionally MRI, revealed white/grey areas in lungs of Tg mice, suggesting fluid retention.
Impaired structural and electrical organization at intercalated discs in
CHAPb Tg hearts
In addition to the morphological and histological changes in Tg heart, we observed changes at
the intercalated discs of cardiomyocytes. In particular, gap junction proteins Cx40 and Cx43
were markedly downregulated in the left atrium of Tg hearts, which was already visible at
three months but more pronounced at six months of age. Since gap junctions are crucial for
fast spreading of action potentials between cardiomyocytes, impaired expression of gap junc-
tions expected to affect electrical guidance. Indeed, decreased connexins expression in the left
atrium correlated with conduction disturbances, evidenced by increased PR interval, the time
required for conduction between atria and ventricles. Loss of expression of Cx40 and 43 has
been associated previously with conduction disturbances in mice. In Cx40-/- mutant mice, var-
ious conduction disturbances have been reported, including increased PR interval [22, 23]. In
Cx43+/- mice ventricular conduction was delayed,[24] although no change in atrial conduction
was observed [25]. In other hypertrophy mouse models, down-regulation of Cx’s in the atria
also correlated with conduction disturbances [26–28].
Although decreased expression of connexins and impaired electrical guidance in Tg mice
was limited to the atria, detailed analysis of individual cardiomyocytes by electronmicroscopy
showed that there was disorganization of Z-discs and intercalated discs throughout the whole
(red). In wt mice RhoA is localized at the membrane of cardiomyocytes and shows a sarcomeric expression
pattern. In CHAPb Tg hearts sarcomeric expression of RhoA is absent and membrane expression is
increased. (D) Western blot analysis of 2 wt and 3 CHAPb Tg hearts at 6 months of age for RhoA (24kDa), α-
actinin (100kDa), actin (42kDa), Ezrin(80 kDa)/moesin(80 kDa)/radixin (75 kDa; ERM), cofilin (19kDa), SRF
(40 – 67kDa) and MEF2 (40-65kDa). GAPDH (38kDa) is used as loading control. (E) Working model: in adult
wt mice CHAPa is localized at the Z-disc, leading to abundance of monomeric G-actin and subsequent low
expression of SRF target genes. In CHAPb Tg mice CHAPb expression results in activation of RhoA, leading
to a shift from G-actin to F-actin, binding of co-factors to SRF and activation of SRF target genes, such as
ANF, BNP and β-MHC. Scale bars 20 μm in A and C, 1 μm in B.
https://doi.org/10.1371/journal.pone.0189139.g006
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heart. Sarcomeric disorganization would suggest impaired contractility and/or relaxation of
cardiac muscle, affecting cardiac function.
CHAPb Tg mice display cardiac diastolic dysfunction
MRI measurements indicated that Tg mice had normal left ventricular ejection fraction. Simi-
larly, in patients with heart failure, almost half (47%) still have a normal ejection fraction [29].
Ejection fraction is determined by differences in both end-diastolic and end-systolic volumes
and if both parameters are changed, as occurs in Tg mice, ejection fraction may be unaffected.
The decreased diastolic volumes observed in Tg mice may suggest impaired relaxation during
diastole (diastolic dysfunction), which relates to impaired Ca2+ cycling in cardiomyocytes.
Contraction of cardiomyocytes is achieved by entry of Ca2+ through L-type channels, which
causes Ca2+ release into the cytosol, immediately followed by Ca2+ release from the sarcoplas-
mic reticulum (SR). Subsequently, Ca2+ binds to sarcomeric protein troponin C to initiate
contraction. On the other hand, relaxation occurs through uptake of the Ca2+ into the SR
via SERCA2. In Tg cardiomyocytes, re-uptake of Ca2+ might be affected, although reduced
SERCA2 mRNA levels in Tg mice did not reach statistical significance [17, 30]. In addition,
measurements in membrane-permeabilized cardiomyocytes revealed reduced force-generat-
ing capacity of Tg sarcomeres, which may in part underlie the significant reduction in cardiac
output observed in Tg compared to wt mice. In primary cardiomyopathy, alterations in Ca2+-
sensitivity have been reported, which may depend on the location of the mutation in affected
genes. Perturbations in Ca2+-sensitivity of the sarcomeres may result in development of HCM
or DCM [31]. As overexpression of CHAPb reduced Ca2+-sensitivity, it would be interesting
to investigate the role of CHAP in primary cardiomyopathy cases.
Activated actin signalling in CHAPb Tg hearts
We found that expression of RhoA is increased in Tg hearts. RhoA belongs to the family of the
small GTPases. Its effects on the actin cytoskeleton are mediated through stimulation of Rho
Kinase (ROCK) [32]. RhoA is expressed in the heart during embryonic development, is down-
regulated after birth and re-expressed in cardiac hypertrophy [33]. Furthermore, RhoA Tg
mice develop a phenotype that resembles DCM, which is accompanied with conduction dis-
turbances [34]. Alternatively, inhibition of ROCK reduces pressure overload-induced hyper-
trophy in rats [35]. It has been previously shown that synaptopodin, is involved in actin stress
fiber formation by preventing proteasomal degradation of RhoA [36]. Like synaptopodin,
CHAPb might be involved in the stabilization of RhoA, which may lead to actin stress fiber
formation and induction of hypertrophy via the Rho-ROCK pathway.
CHAP is involved in the SRF/MEF-2 actin signalling pathway
We observed increased expression of transcription factors SRF and MEF-2 in Tg hearts. Previ-
ously, it has been demonstrated that Striated muscle activator of Rho signalling (STARS), an
actin-bundling protein localized at the Z-disc, is associated with both SRF and MEF-2 signal-
ling. STARS is induced by MEF-2, which in turn regulates the formation of F-actin fibers via
RhoA, leading to depletion of the monomeric globular actin (G-actin) pool. Consequently, a
reduction of G-actin may lead to activation of SRF mediated transcription [37–39]. Previous
studies in mice have indicated the relevance of SRF in the development of cardiomyopathy
[40, 41]. In addition, the importance of SRF in cardiomyocyte function, maintenance and reg-
ulation was shown in experiments in which it was knocked-down: expression of cytoskeletal
genes, such as α- and β-MHC, cardiac α-actin and smooth muscle actin were decreased and
also, interestingly, CHAP [42, 43]. With respect to the MEF2 transcription factor family
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(MEF-2a, c and d), Tg mice overexpressing these genes in the heart also showed cardiac hyper-
trophy and stress-dependent cardiac remodelling [44–46]. The phenotypes of the different Tg
models do not overlap completely with the phenotype observed here, suggesting that addi-
tional pathways may be involved in the CHAPb induced hypertrophy. In summary, our study
suggests a model in which increased levels of CHAPb may activate actin signalling leading to
subsequent activation of cardiac transcription factors MEF2 and SRF, initiating a hypertrophic
response and structural and functional changes in cardiomyocytes (Fig 6E).
Conclusion
We show that postnatal re-expression of the embryonic isoform of CHAP, CHAPb, is suffi-
cient to cause cardiomyopathy with diastolic cardiac dysfunction and conduction distur-
bances, which is associated with sarcomere dysfunction and activation of actin signalling and
of the downstream transcription factors MEF-2 and SRF. Recently, Kong et al [4] demon-
strated that apart from alterations in gene expression, changes in alternative mRNAs of sarco-
meric genes particularly are associated with heart failure. These findings and our study
demonstrate the importance of correct dosage of sarcomeric gene isoforms and substantiate
further investigation in developmentally (dys-) regulated alternative isoforms of other cardiac
gene products.
Recently the genomic locus of CHAP (SYNPO2L) has been associated with AF and blood
pressure regulation [9–11, 47], which suggests that CHAP is a clinically relevant gene. The
functional role of CHAP in AF and regulation of blood pressure remains elusive. It is therefore
important to perform in depth functional studies of CHAP in vivo to gain insight in the molec-
ular mechanism of disease.
Taken together, our results identify CHAPb as a novel component in the pathology of car-
diomyopathy, a potential therapeutic target, and new candidate gene for screening mutations
in familial cardiomyopathies and atrial fibrillation.
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S1 Fig. Genomic organization and isoforms of mus musculus Chap. (A) Genomic organiza-
tion of the mouse Chap gene on chromosome 14 (B) mRNA isoforms of CHAP resulting from
differential usage of transcriptional start sites (C) CHAPa and CHAPb protein isoforms.
(JPG)
S2 Fig. Generation and validation of Chap B TG mouse. (A) Schematic overview showing
the construct used to generate transgenic mice. FLAG-CHAPb cDNA is downstream of the α-
MHC promoter and upstream a human Growth Hormone polyA signal. (B) Southern blot
analysis of wild type and CHAPb Tg genomic DNA showing intermediate copy number in
line 14 and high copy number in line 29, compared to wild type copy numbers. Hearts of
CHAPb founder line 29 (left panels) and line 14 (right panels). (C) qPCR analysis of ChapB in
wt (white bars, n = 6) and CHAPb Tg hearts (black bars, n = 3). Gapdh was used as internal
control (D) Western blot showing CHAP and FLAG expression in wt (n = 2) and CHAPb Tg
(n = 3) hearts. GAPDH was used as loading control.
(JPG)
S3 Fig. Hearts of CHAPb Tg founders that died spontaneously. (A) Hearts showing
enlarged atria and malformed ventricles. (B) HE stained overview section showing enlarged
atria and thickened ventricles. (C) Higher magnification of the left ventricle. Scale bars in B 1
mm, in C 50 μm.
(JPG)
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S4 Fig. HE and Sirius red staining of CHAPb Tg hearts at one month of age. Wt (left panels)
and CHAPb Tg (right panels) at 1 month of age (A-C). A) HE stained overview section. (B)
Higher magnification of left ventricle. (C) Sirius red staining of the left ventricle. (D-E) Vol-
ume of the left atrium (D) and right atrium (E) in wt (n = 4, white bars) and CHAPb Tg (n = 4,
black bars) hearts (t-test, NS). Scale bars 1 mm in A, 50 μm in B, C.
(JPG)
S5 Fig. Interstitial fibrosis in CHAPb Tg left atrium at six months of age. Sirius red staining
on atrial sections of wild type (left panel) and CHAPb Tg mice shows increased interstitial
fibrosis and increased myocytes size in CHAPb Tg atria.
(JPG)
S6 Fig. Expression of Connexin 40 and 43 at 1, 3 and 6 months. Immunohistochemical
staining showing Connexin 40 (A and C) and 43 (B and D) expression in wt (left panels) and
CHAPb Tg (right panels) left atria (A, B and upper panels of C and D) and right atria (lower
panels of C and D) at one month (A and B) and 3 months of age (C and D) of age. qPCR analy-
sis of Connexin 43 (E and F) expression in the left (E) and right (F) atrium at 6 months of age
(wt, n = 3; Tg, n = 3; T-test: ,p<0.01). (G) Heart rate as determined by ECG in wild type and
Tg mice (wt, n = 4; Tg n = 8; t-test: NS). Scale bars 50 μm.
(JPG)
S7 Fig. Functional analysis of CHAPb Tg hearts. MRI measurements of the right ventricle of
wt (n = 4, white bars) and CHAPb Tg (n = 5 black bars) animals at 6 months of age (A-D, t-
test: , p<0.05; , p<0.01). ED volume (A), ES volume (B), ejection fraction (C) and cardiac
output (D). ED (end diastolic), ES (end systolic) and LV (left ventricular).
(JPG)
S8 Fig. Phosphorylation of sarcomeric proteins is not affected in 3-month-old CHAPb Tg
mice left ventricles. (A) Representative image of a Pro-Q Diamond stained polyacrylamide
gel that shows phosphorylated proteins (left panel). Representative image of a SYPRO Ruby
total protein gel staining (right panel) (B) Quantification of phosphorylated MyBP-C, cTnT,
cTnI and MLC2 in wildtype hearts (n = 5 mice) and CHAPb Tg hearts (n = 3 mice). No statis-
tically significant difference in phosphorylation was found between wildtype and CHAPb Tg
mice. (2-tailed unpaired t-test).
(JPG)
S9 Fig. Expression of M-band protein myomesin is not affected in CHAPb Tg hearts.
Hearts stained for CHAP (green) / myomesin (red), merge images are shown. CHAP is local-
ized in the Z-disc of cardiomyocytes of wt (upper panels) hearts. In cardiomyocytes of CHAPb
Tg (lower panels) CHAP also stained stress fibers (arrows), which did not stain for myomesin.
Scale bars: 20 μm.
(JPG)
S10 Fig. Ectopic pERM expression in CHAPb Tg hearts. Wt (upper panels) and CHAPb Tg
(lower panels) hearts at 6 months of age stained for pERM (green) and alpha-actinin (red).
Nuclei are stained blue, merge images are shown. Scale bars: 20 μm.
(JPG)
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